EUVIMEDEUVIMED entdecken
Crossref

Psychotropic Classes Concomitant with Stimulants and the Association with the Risk of Diabetes in Medicaid-Insured Youth

Yue Zhu, Julie M Zito, James F Gardner, Heather A Young, Scott Quinlan, Angelo Elmi

Journal of Child and Adolescent Psychopharmacology · 2026

DOI: 10.1177/10445463251401518 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, 2026. Verfasst von Yue Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Milken Institute School of Public Health, George Washington University, Washington, District of Columbia, USA. Hauptthemen laut MEDLINE: Central Nervous System Stimulants, Psychotropic Drugs, Diabetes Mellitus, Mental Disorders. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance: Psychotropic classes concomitant with stimulants (PCCWS) in children and adolescents have shown an inconsistent impact on the risk of diabetes mellitus. PCCWS with 2–5 classes is common but the risk of diabetes subsequent to stimulant initiation is unknown.

Objective

To assess the risk of diabetes in youth with PCCWS regimens with 2–5 additional psychotropic classes.

Design

A retrospective cohort study was conducted using Medicaid claims data from 2007–2014. Youth aged 2–17 years with 1–7.5 years of continuous enrollment who were new stimulant users with clinician-reported psychiatric diagnosis were followed.

Setting

Outpatient clinic and inpatient records for statewide Medicaid-insured youth in a mid-Atlantic state.

Participants

The study cohort comprised 30,112 youth with an average follow-up of 6.4 years. Exposures: Among stimulant users, five groups were defined according to concomitant use. Main Outcomes and Measures: The major outcome is diabetes risk and was assessed using discrete-time failure models, after adjustment for disease risk score which was categorized using more than 120 baseline and time-dependent covariates.

Results

Among 30,112 new stimulant users, 43 were new diabetes patients and 30,069 were nondiabetes patients. The absolute risk of diabetes in youth had an eight-fold increase from 3 to 5 class PCCWS regimens that included antipsychotics, antidepressants, or anticonvulsant-mood stabilizers (0.5; 1.13; 4.20 per 10,000 person-months, respectively). Compared with stimulant monotherapy, PCCWS with any of these 3 classes were significantly more likely to develop diabetes (adjusted relative risk [ARR], 2.58, (95% CI 1.05–6.82); 5.81, (2.29–14.75); 18.91, (6.07–58.90) for 3, 4 and 5 class PCCWS, respectively). Similarly, there was a significantly greater risk of diabetes for those with 120–779 days of cumulative duration than for shorter exposures, and in 4 and 5 class combined PCCWS including antipsychotics, antidepressants, or anticonvulsant-mood stabilizers [ARR, 3.78, (1.16–12.40)].

Conclusions

In a large Medicaid-insured, long-enrolled youth cohort, the use of PCCWS, particularly concomitant use with antipsychotic, antidepressant, and/or antipsychotic-mood stabilizers, and with long duration of these combinations were associated with an increased risk of diabetes. Relevance: The findings support a call for corroboration in a large national cohort of continuously enrolled Medicaid-insured pediatric youth with long follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Nervous System StimulantsPsychotropic DrugsDiabetes MellitusMental DisordersHumansChildMedicaidAdolescentMaleFemaleUnited StatesRetrospective StudiesChild, PreschoolCohort Studies

Stichwörter der Autor:innen

Medicaidlong-term usepolypharmacyrisk of diabetesstimulantsyouth

Substanzen

Central Nervous System StimulantsPsychotropic Drugs

Autor:innen und Institutionen

  • Milken Institute School of Public Health, George Washington University, Washington, District of Columbia, USA.
  • Department of Practice, Sciences, and Health Outcomes Research, University of Maryland, Baltimore, Maryland, USA.
  • School of Medicine Dept of Psychiatry, Baltimore, Maryland, USA.

Zitieren

APA

Zhu, Y., Zito, J. M., Gardner, J. F., Young, H. A., Quinlan, S., & Elmi, A. (2026). Psychotropic Classes Concomitant with Stimulants and the Association with the Risk of Diabetes in Medicaid-Insured Youth. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1177/10445463251401518

Vancouver

Zhu Y, Zito JM, Gardner JF, Young HA, Quinlan S, Elmi A. Psychotropic Classes Concomitant with Stimulants and the Association with the Risk of Diabetes in Medicaid-Insured Youth. Journal of Child and Adolescent Psychopharmacology. 2026. doi:10.1177/10445463251401518

BibTeX
@article{Zhu2026,
  author = {Zhu, Yue and Zito, Julie M and Gardner, James F and Young, Heather A and Quinlan, Scott and Elmi, Angelo},
  title = {Psychotropic Classes Concomitant with Stimulants and the Association with the Risk of Diabetes in Medicaid-Insured Youth},
  journal = {Journal of Child and Adolescent Psychopharmacology},
  year = {2026},
  doi = {10.1177/10445463251401518}
}
Kostenlos starten →